BIA
RVMD icon

Bell Investment Advisors’s Revolution Medicines RVMD Stock Holding History

Bell Investment Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Sell
112
-3
-3% -$438 ﹤0.01% 456
2026
Q1 		$11.2K Buy
115
+9
+8% +$909 ﹤0.01% 636
2025
Q4 		$8.44K Buy
106
+6
+6% +$393 ﹤0.01% 754
2025
Q3 		$4.67K Hold
100
– – ﹤0.01% 967
2025
Q2 		$3.68K Buy
100
+51
+104% +$1.96K ﹤0.01% 1128
2025
Q1 		$1.73K Hold
49
– – ﹤0.01% 1359
2024
Q4 		$2.14K Hold
49
– – ﹤0.01% 1307
2024
Q3 		$2.22K Buy
49
+12
+32% +$523 ﹤0.01% 1315
2024
Q2 		$1.44K Hold
37
– – ﹤0.01% 1486
2024
Q1 		$1.19K Hold
37
– – ﹤0.01% 1551
2023
Q4 		$1.06K Buy
+37
New +$889 ﹤0.01% 1574
2021
Q4 		$1K Buy
20
+4
+25% +$113 ﹤0.01% 1582
2021
Q3 		$0 Buy
+16
New +$466 ﹤0.01% 1811

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bell Investment Advisors's RVMD Position: Q2 2026 in Review

Bell Investment Advisors reduced its Revolution Medicines (RVMD) stake by 2.6% in Q2 2026, selling an estimated $438 and leaving 112 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Bell Investment Advisors first reported a position in RVMD in Q3 2021 and has held it in 13 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bell Investment Advisors held 112 shares of Revolution Medicines worth $21K as of Q2 2026.
  • Bell Investment Advisors sold 3 Revolution Medicines shares in Q2 2026, an estimated $438.
  • Revolution Medicines made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #456 holding.
  • Bell Investment Advisors first reported a position in Revolution Medicines in Q3 2021 and has held it in 13 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.